[Sporadic Cerebral Amyloid Angiopathy: An Overview with Clinical Cases]

Fortschr Neurol Psychiatr. 2016 Sep;84(9):534-41. doi: 10.1055/s-0042-109537. Epub 2016 Sep 8.
[Article in German]

Abstract

Sporadic cerebral amyloid angiopathy (CAA) is a cerebral small vessel disease in the elderly. Neuropathologically, it is characterized by deposition of amyloid-ß (Aß) in the wall of small to medium-sized arteries, capillaries and venules of the cerebral cortex and leptomeninges. Over the last years it was recognized as an important cause of spontaneous intracerebral hemorrhage and cognitive deficits in the elderly. The clinical and radiological manifestations are diverse ranging from acute onset focal neurological deficits due to intracerebral lobar hemorrhage to subacute progressive cognitive impairment due to Aß-mediated inflammation confluent subcortical edema. The wide clinico-radiological spectrum of CAA is a major challenge for the neurologist and stroke physician. This review provides a structured and detailed look at recent developments in CAA, and is illustrated with case studies.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Amyloid beta-Peptides / metabolism
  • Cerebral Amyloid Angiopathy / diagnosis*
  • Cerebral Amyloid Angiopathy / pathology*
  • Cerebral Arteries / pathology
  • Cerebral Cortex / blood supply
  • Cerebral Cortex / pathology
  • Cerebral Hemorrhage / diagnosis*
  • Cerebral Hemorrhage / pathology*
  • Cerebral Veins / pathology
  • Cognitive Dysfunction / diagnosis
  • Cognitive Dysfunction / pathology
  • Disease Progression
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Meninges / blood supply
  • Middle Aged
  • Peptide Fragments / metabolism

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • amyloid beta-protein (1-42)